Last reviewed · How we verify

NCT07347652: DVT

This Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thrombosis (DVT) in Patients Undergoing On-pump Cardiac Surgery. The Study Will Include an Intervention Group That Receives the Nursing Protocol and a Control Group That Receives Routine

Active, enrolled NA Last updated 16 January 2026
What this trial tests

NA trial testing IPC devices facilitate venous return by simulating the physiological effects of muscle contraction, reducing venous stasis. in On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications in 67 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 June 2025
Primary endpoint
25 December 2025
28 March 2026

Quick facts

Lead sponsorNear East University, Turkey
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment67
Start date14 June 2025
Primary completion25 December 2025
Estimated completion28 March 2026
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Near East University, Turkey

Who can join

Eligibility, any sex, with On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications or DVT - Deep Vein Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary focus of this research proposal is to examine the efficacy of a nursing care protocol in preventing the occurrence of deep vein thrombosis (DVT) in patients undergoing on-pump cardiac surgery. The investigation will encompass an experimental group that will be subjected to a specific intervention, alongside a control group that will adhere to conventional care procedures. The central objective is to exhibit a statistically significant decrease in the incidence of DVT within the experimental group in comparison to the control group. The secondary outcomes involve assessing the severity of DVT instances and the development of associated complications. The proposed research strategy entails delineating the criteria for selecting participants, outlining methodologies for gathering data, and detailing statistical approaches for analysis. The amassed data will undergo scrutiny through suitable statistical examinations, including chi-square tests, t-tests, or Mann-Whitney U tests, as well as logistic regression analysis. The process of data analysis will involve descriptive statistics, comparative assessments, regression analysis, and subgroup scrutiny. The interpretation of outcomes will be contextualized within the framework of the research objectives and pre-existing scientific knowledge. The ultimate objective of this study is to enhance the existing understanding of DVT prevention, provide clinically grounded recommendations supported by evidence, and elevate the quality and safety of patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Near East University, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07347652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing